Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × denileukin diftitox × Clear all

NCT00726037 2016-09-29

A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer

Phase 2 Terminated

7 enrolled 3 charts

Gastrointestinal

Pancreatic Neoplasms